←Back to Expert Scholars
Translational Medicine / 转化医学Squamous NSCLC Advances
Frances Shepherd
MD
🏢Princess Margaret Cancer Centre / University of Toronto🌐Canada
Professor Emeritus
92
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Frances Shepherd is a senior thoracic oncologist who led the landmark BR.21 erlotinib trial. Her work has shaped global NSCLC treatment standards across histology subtypes. She mentored a generation of Canadian lung cancer investigators.
Share:
🧪Research Fields 研究领域
NSCLC trials
Erlotinib
BR.21 study
Cooperative group trials
Second-line therapy
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Frances Shepherd 的研究动态
Follow Frances Shepherd's research updates
留下邮箱，当我们发布与 Frances Shepherd（Princess Margaret Cancer Centre / University of Toronto）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment